Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 13/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | ALPL | P05186 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | TRPC4 | Q9UBN4 | 1/20 | 0.33 |
| ▸ | TRPC5 | Q9UL62 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1875007 | 0.87 | ADORA1 (0.55) | ADORA1ADORA3ADORA2BALPLADORA2A | |
| SCHEMBL1871234 | 0.84 | ADORA1 (0.47) | ADORA1ADORA3ADORA2BTRPC4TRPC5 | |
| SCHEMBL1864689 | 0.81 | ADORA1 (0.44) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL1870705 | 0.81 | ADORA1 (0.42) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL1861450 | 0.81 | ADORA1 (0.49) | ADORA1ADORA3ADORA2BADORA2AHCRTR2 | |
| SCHEMBL1869240 | 0.79 | ADORA1 (0.38) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL1869009 | 0.79 | ADORA1 (0.47) | ADORA1ADORA3ADORA2BALPL | |
| SCHEMBL1871420 | 0.78 | ADORA1 (0.41) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL1866382 | 0.77 | ADORA1 (0.57) | ADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL1865763 | 0.77 | ADORA1 (0.37) | ADORA1ADORA3ADORA2BADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2499142-A1 | SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF | Advinus Therapeutics Limited (IN) | 2012-09-19 | — | — | EP | claimed |
| WO-2011055391-A1 | SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF | ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) | 2011-05-12 | — | — | WO | claimed |
| EP-2499142-A1 | SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF | Advinus Therapeutics Limited (IN) | 2012-09-19 | — | — | EP | disclosed |
| WO-2011055391-A1 | SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF | ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) | 2011-05-12 | — | — | WO | disclosed |